Neothetics to Present at Needham & Company's 14th Annual Healthcare Conference

SAN DIEGO, April 8, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq: NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that George Mahaffey, president and chief executive officer, will present at Needham & Company's 14th Annual Healthcare Conference in New York City on Wednesday, April 15th at 11:20 a.m. ET/8:20 a.m. PT. The conference will be held at the Westin New York Grand Central Hotel.

A live audio webcast can be accessed in the "Investor" section of the company website, www.neothetics.com, with an archived version available for up to 90 days following the conference.

About Neothetics, Inc.

Neothetics is a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market. The lead product candidate, LIPO-202, is for the reduction of subcutaneous fat in the central abdomen in non-obese patients, an indication for which there is no FDA-approved drug. If approved, LIPO-202 may be a best-in-class non-surgical, non-ablative procedure and first-in-class injectable formulation for localized fat reduction and body contouring. For more information on Neothetics, please visit www.neothetics.com.

Neothetics, LIPO-202, LIPO-102 and the Neothetics logo are trademarks or registered trademarks of Neothetics, Inc. Other names and brands may be claimed as the property of others.

CONTACT: COMPANY CONTACT:
         Susan A. Knudson
         Chief Financial Officer
         858-750-1008
         [email protected]

         INVESTOR CONTACT:
         Fara Berkowitz
         Investor Relations and Corporate Strategy
         [email protected]

         MEDIA CONTACT:
         Rachel Hutman
         Canale Communications
         619-849-5384
         [email protected]

You May Also Be Interested In

• Liberate Recognized with 16 Brandon Hall Group™ HCM Excellence Awards® in 2026
• EagleNXT Named 'Crop Monitoring Solution of the Year' at AgTech Breakthrough Awards
• Attorneys from Houston's Alavi Anaipakos Featured in 2027 Best Lawyers in America